Other papers submitted by: Dr Jibo Han

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Jibo Han

Papers published by Dr Jibo Han:

Original Research

Highly-accessed

AZD4547 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting Inflammation: The Role of FGFR1 in Renal Tubular Epithelial Cells

Chen X, Zhang X, Xu J, Zhao Y, Bao J, Zheng Z, Han J

Drug Design, Development and Therapy 2020, 14:833-844

Published Date: 26 February 2020

Original Research

Noteworthy comment: A large number of in vivo and in vitro tests indicate that ischemia/reperfusion injury may cause pyroptosis in cardiomyocytes in rats and emodin can alleviate it, presenting a potential new mechanism by which emodin protects cardiomyocyte ischemia/reperfusion injury. The work is very interesting and represents a contribution in the management of myocardial ischemic processes that has increased significantly in recent years.

Highly-accessed

Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes

Ye B, Chen X, Dai S, Han J, Liang X, Lin S, Cai X, Huang Z, Huang W

Drug Design, Development and Therapy 2019, 13:975-990

Published Date: 25 March 2019

Original Research

Highly-accessed

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Han J, Shi X, Zheng Z, Zhang B, Shi F, Jiang L, Xu J

Drug Design, Development and Therapy 2018, 12:3985-3997

Published Date: 22 November 2018